Ardelyx stock rockets again on massive volume, after plans to launch IBS-C treatment announcedMarket Watch • 12/01/21
Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021PRNewsWire • 11/05/21
Ardelyx: Indecisive Regulators, Frustrated Company, Gruelling Wait For InvestorsSeeking Alpha • 10/25/21
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Ardelyx Inc. Investors in Securities Fraud Class Action LawsuitBusiness Wire • 09/30/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDXNewsfile Corp • 09/28/21
ARDX Final Deadline Today: Rosen, National Trial Lawyers, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDXNewsfile Corp • 09/28/21
Ardelyx Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 09/28/21
LAWSUITS FILED AGAINST ARDX, HYRE and WDH - Jakubowitz Law Pursues Shareholders ClaimsAccesswire • 09/27/21
ARDX Final Deadline Tomorrow: Rosen, a Leading Investor Rights Law Firm, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDXNewsfile Corp • 09/27/21
Last Few Hours to Actively Participate in Ardelyx, Inc. (ARDX) Class Action: Bronstein, Gewirtz & Grossman, LLCNewsfile Corp • 09/27/21